Following the UK’s exit from the European Union, the Medicines and Healthcare products Regulatory Agency (MHRA) is now the UK’s standalone medicines and medical device regulator. This means that any medical devices imported to and sold within the UK must comply and be registered with the MHRA.
Regulatory compliance and quality assurance have always been priorities for the Straumann Group. As such, Straumann UK has been appointed as the UK Responsible Person and will act on behalf of all Straumann Group companies in this capacity.
Straumann UK has completed all the necessary registrations for Straumann Group products, including Straumann, Anthogyr, Neodent, ClearCorrect, Createch, Medentika, Valoc and Dental Wings.
Steve Booth, managing director of Straumann UK, comments, “The Straumann Group remains committed to the highest industry standards here in the UK and around the world. We appreciate the on-going trust our customers put in us to deliver effective, safe and compliant solutions, so we remain vigilant of any industry changes that may impact our product portfolio or our customers. This is just one way in which we stay at the cutting-edge of the global dental profession.”